Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Withdrawn 2Completed 2

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 4Endometrial Neoplasms 4Breast Neoplasms 2Triple Negative Breast Neoplasms 1Treatment for Metastatic or Locally Advanced Cervical Cancer 1Recurrence 1Pancreatic Neoplasms 1Neoplasm Metastasis 1Colonic Neoplasms 1Advanced Endometrial Cancer 1

Interventions

Paclitaxel 95Carboplatin 77pembrolizumab 74Cisplatin 29Bevacizumab 27Surveys and Questionnaires 23Radiotherapy 22Letrozole 22Doxorubicin 21Megestrol Acetate 20olaparib 19lenvatinib 19Taxes 17Specimen Handling 17Docetaxel 17Nivolumab 16Magnetic Resonance Spectroscopy 16dostarlimab 15Metformin 15Blood Specimen Collection 14Observation 13Gemcitabine 13Biopsy 13durvalumab 12Medroxyprogesterone Acetate 12Trastuzumab 11Indocyanine Green 11Fulvestrant 11temsirolimus 10abemaciclib 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Endometrial Neoplasms × NVP-BKM120 × Gynecologic × Clear all
NCT01397877 2023-09-06

ENDOPIK

ARCAGY/ GINECO GROUP

Phase 2 Completed
24 enrolled
Gynecologic

Neoplasm Metastasis, Endometrial Neoplasms

NCT02117817 2022-07-28

Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer

Rutgers, The State University of New Jersey

Phase 1 Withdrawn
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT01068483 2020-12-08

Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients

Novartis

Phase 1 Completed
107 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT01550380 2014-07-29

BKM120

University of Utah

Phase 2 Withdrawn
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡